Positron lymphography: Multimodal, high-resolution, dynamic mapping and resection of lymph nodes after intradermal injection of 18F-FDG

Journal of Nuclear Medicine

Volumn 53, Issue 9, 2012, Pages 1438-1445

  Thorek, Daniel L J ^a   Abou, Diane S ^a   Beattie, Bradley J ^a   Bartlett, Rachel M ^a   Huang, Ruimin ^a   Zanzonico, Pat B ^a   Grimm, Jan ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cerenkov; Intraoperative; Lymph node mapping; PET CT

Indexed keywords

CONTRAST MEDIUM; DYE; FLUORODEOXYGLUCOSE F 18; TECHNETIUM SULFUR COLLOID TC 99M; TRACER;

ANIMAL EXPERIMENT; ARTICLE; DIAGNOSTIC IMAGING; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHADENECTOMY; LYMPHATIC SYSTEM; LYMPHOGRAPHY; LYMPHOSCINTIGRAPHY; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; POSITRON LYMPHOGRAPHY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; ELECTRONS; FEMALE; FLUORODEOXYGLUCOSE F18; INJECTIONS, INTRADERMAL; LYMPH NODES; LYMPHOGRAPHY; MALE; MICE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREOPERATIVE PERIOD;

EID: 84866182584     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.104349     Document Type: Article

References (39)

1. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature. 2005;438:946-953.
2. Lucey BC, Stuhlfaut JW, Soto JA. Mesenteric lymph nodes seen at imaging: causes and significance. Radiographics. 2005;25:351-365.
3. Balch CM, Buzaid AC, Soong S-J, et al. Final version of the American Joint Committee on Cancer Staging System for cutaneous melanoma. J Clin Oncol. 2001;19:3635-3648.
4. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976-983.
5. Pagliarulo V, Hawes D, Brands FH, et al. Detection of occult lymph node metastases in locally advanced node-negative prostate cancer. J Clin Oncol. 2006;24:2735-2742.
6. Tinga DJ, Timmer PR, Bouma J, Aalders JG. Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB. Gynecol Oncol. 1990;39:175-180.
7. Delgado G, Bundy B, Zaino R, Sevin B-U, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage ib squamous cell carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol. 1990;38:352-357.
8. McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000;18:2560-2566.
9. Fisher ER, Costantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: five-year observations concerning lobular carcinoma in situ. Cancer. 1996;78:1403-1416.
10. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph-node status, and survival in 24,740 breast-cancer cases. Cancer. 1989;63:181-187.
11. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348:2491-2499.
12. Larson SM, Nelp WB. Radiopharmacology of a simplified technetium-99m-colloid preparation for photoscanning. J Nucl Med. 1966;7:817-826.
13. Mortimer PS, Simmonds R, Rezvani M, Robbins M, Hopewell JW, Ryan TJ. The measurement of skin lymph flow by isotope clearance; reliability, reproducibility, injection dynamics, and the effect of massage. J Invest Dermatol. 1990;95:677-682.
14. 18F-fluorodeoxyglucose-positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer. Int J Gynecol Cancer. 2009;19:1412-1414.
15. Hirsch J, Tisnado J. Cho, Beachley M. Use of isosulfan blue for identification of lymphatic vessels: Experimental and clinical evaluation. AJR. 1982;139:1061-1064.
16. Sevick-Muraca EM. Translation of near-infrared fluorescence imaging technologies: emerging clinical applications. Annu Rev Med. 2012;63:217-231.
17. Tsien RY. Imagining imaging's future. Nat Rev Mol Cell Biol. 2003;(suppl):SS16-SS21.
18. 89Zr- nanocolloidal albumin-based PET/CT lymphoscintigraphy for sentinel node detection in head and neck cancer: preclinical results. J Nucl Med. 2011;52:1580-1584.
19. Ballou B, Ernst LA, Andreko S, et al. Sentinel lymph node imaging using quantum dots in mouse tumor models. Bioconjug Chem. 2007;18:389-396.
20. Clark WH, Mihm MC Jr, Reed RJ, Ainsworth AM. The lymphocytic infiltrates of the skin. Hum Pathol. 1974;5:25-43.
21. Robertson R, Germanos MS, Li C, Mitchell GS, Cherry SR, Silva MD. Optical imaging of Cerenkov light generation from positron-emitting radiotracers. Phys Med Biol. 2009;54:N355-N365.
22. Ruggiero A, Holland JP, Lewis JS, Grimm J. Cerenkov luminescence imaging of medical isotopes. J Nucl Med. 2010;51:1123-1130.
23. Holland JP, Normand G, Ruggiero A, Lewis JS, Grimm J. Intraoperative imaging of positron emission tomographic radiotracers using Cerenkov luminescence emissions. Mol Imaging. 2011;10:177-186.
24. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press; 1996.
25. Beattie BJ, Forster GJ, Govantes R, et al. Multimodality registration without a dedicated multimodality scanner. Mol Imaging. 2007;6:108-120.
26. Qi J, Leahy RM, Cherry SR, Chatziioannou A, Farquhar TH. High-resolution 3D Bayesian image reconstruction using the micropet small-animal scanner. Phys Med Biol. 1998;43:1001-1013.
27. Beattie BJ, Thorek DL, Schmidtlein CR, Pentlow KS, Humm JL, Hielscher AH. Quantitative modeling of Cerenkov light production efficiency from medical radionuclides. PLoS ONE. 2012;7:e31402.
28. Boardman KC, Swartz MA. Interstitial flow as a guide for lymphangiogenesis. Circ Res. 2003;92:801-808.
29. Clavin NW, Avraham T, Fernandez J, et al. TGF-b1 is a negative regulator of lymphatic regeneration during wound repair. Am J Physiol Heart Circ Physiol. 2008;295:H2113-H2127.
30. Yan A, Avraham T, Zampell JC, Aschen SZ, Mehrara BJ. Mechanisms of lymphatic regeneration after tissue transfer. PLoS ONE. 2011;6:e17201.
31. Kriehuber E, Breiteneder-Geleff S, Groeger M, et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med. 2001;194:797-808.
32. Matsui K, Breitender-Geleff S, Soleiman A, Kowalski H, Kerjaschki D. Podoplanin, a novel 43-kDa membrane protein, controls the shape of podocytes. Nephrol Dial Transplant. 1999;14(suppl 1):9-11.
33. Ordóñez NG. Podoplanin: a novel diagnostic immunohistochemical marker. Adv Anat Pathol. 2006;13:83-88.
34. 18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer. Nucl Med Commun. 2010;31:39-45.
35. Wahl RL, Kaminski MS, Ethier SP, Hutchins GD. The potential of 2-deoxy-2 [18f]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes. J Nucl Med. 1990;31:1831-1835.
36. Wilhelm AJ, Mijnhout GS, Franssen EJ. Radiopharmaceuticals in sentinel lymphnode detection: an overview. Eur J Nucl Med. 1999;26(4, suppl):S36-S42.
37. Vermeeren L, Valdés Olmos RA, Meinhardt W, et al. Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate carcinoma. J Nucl Med. 2009;50:865-870.
38. Servais EL, Colovos C, Bograd AJ, White J, Sadelain M, Adusumilli PS. Animal models and molecular imaging tools to investigate lymph node metastases. J Mol Medm (Berl). 2011;89:753-769.
39. Albo D, Wayne JD, Hunt KK, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg. 2001;182:393-398.